Humacyte HUMA
NASDAQ HUMA
$0.53 +0.02 (+4.47%)
As of: Oct 2, 2026 · 2:20 PM EDT

Humacyte (HUMA) Other Accumulated Expenses (2023 - 2025)

Updated

Humacyte's Other Accumulated Expenses was $185,000 in Q4 2025, down 22.3% from $238,000 a year earlier.

Analysis

Humacyte (HUMA) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

From Q4 2023 onward, Humacyte has reported Other Accumulated Expenses for 5 quarters.

  • In earlier years, Other Accumulated Expenses was $238,000 in FY2024 (+349.1%) and $53,000 in FY2023.
  • Quarterly Other Accumulated Expenses has moved between $53,000 (Q4 2023) and $238,000 (Q4 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 185,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 60,000.00
Dec 31, 2024 238,000.00
Dec 31, 2023 53,000.00
API Access

Humacyte Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=HUMA&period=max&api_key=YOUR_API_KEY